Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IRAK1/4 |
Trade Name | |
Synonyms | |
Drug Descriptions |
IRAK1/4 is an inhibitor of interleukin-1 receptor associated kinases 1 and 4, which results in stabilization of wild-type KMT2A, thereby potentially leading to inhibition of cell growth and delayed disease progression in KMT2A fusion specific cancers (PMID: 28065413, PMID: 32489949). |
DrugClasses | IRAK1/4 Inhibitor 2 |
CAS Registry Number | 509093-47-4 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IRAK1/4 | IRAK1/4 | 0 | 0 |